
Professor Jason Johnson
MSc, PhD
Expertise
Current positions
Professor of Cardiovascular Pathology
Bristol Medical School (THS)
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Research interests
Professor Jason Johnson is a past-holder of a British Heart Foundation Senior Research Fellowship and leads the Laboratory of Cardiovascular Pathology at the University of Bristol.
He has a long-standing interest in the pathophysiology of numerous cardiovascular pathologies including atherosclerosis, aortic aneurysms, and restenosis. His studies include a marriage of basic science and translational cardiovascular research with the goal of facilitating the development and deployment of novel therapies to combat the aforementioned cardiovascular diseases, alongside the identification of potential biomarkers of disease progression.
Since gaining his PhD in 2005, Professor Johnson’s research has underpinned the dogma that not all matrix metalloproteinases (MMPs) play detrimental roles in atherosclerotic plaque progression. Moreover, he has aided the identification of a macrophage phenotype (under the control of GM-CSF) which is characterised by high MMP-12 and MMP-14 protein expression alongside low TIMP-3 levels. Further work has also identified a novel node of microRNA regulation within GM-CSF macrophages, highlighting several potential new therapeutic avenues, including miR-181b inhibition and the selective inhibition of MMP-12. Collectively, these studies have made a major contribution to understanding the role of matrix metalloproteinases and macrophage heterogeneity in atherosclerotic plaque progression. Supporting studies in human aneurysm samples and pertinent pre-clinical in vivo models has reaffirmed the notion that the proteolytic profile of macrophage subsets predicts aneurysm development and progression. These findings are now being tested in a novel ex vivo human model of aneurysm that will hopefully supplant the requirement for animal studies. Recent new therapies and biomarkers for atherosclerosis and related pathologies are now being explored through industrial collaborations.
Publication metrics (from Google Scholar):
Number of publications – 102
Sum of total citations – 8336
Avg citations per item as 1st or senior author- 157
Number of citations last year (2023) – 518
H-index – 49
Current and Past Academic Leadership and Citizenship Roles:
- Secretary of the British Atherosclerosis Society
- British Heart Foundation Project Grant Committee (2012-2015)
- Member of the British Council Research Links Grants Committee (2015-ongoing)
- Editorial Board Membership (Cardiovascular Research, and Vascular Pharmacology)
- British Atherosclerosis Society John French Lecturer 2015
- Member of the European Society of Cardiology Working Group on Pathogenesis of Atherosclerosis
- Member of the American Heart Association (councils of ATVB, and Basic Cardiovascular Sciences)
- Co-Director of Research (Cardiovascular) for Bristol Medical School
- Deputy Head of Research for School of Clinical Sciences
- External examiner iBSc in Cardiovascular Research University of Sheffield
Projects and supervisions
Research projects
Development and characterisation of a human ex vivo model of aneurysm
Principal Investigator
Managing organisational unit
Bristol Medical School (THS)Dates
15/02/2016 to 14/02/2019
Pre-clinical evaluation of MMP-12 inhibition for the prevention and treatment of abdominal aortic aneurysm formation and progression
Principal Investigator
Managing organisational unit
Bristol Medical School (THS)Dates
21/08/2015 to 20/08/2017
Thesis supervisions
The role of PRH/HHEX in the modulation of endothelial cell and intimal hyperplasia: implications of vein graft disease
Supervisors
Development and characterisation of a human ex vivo model of aneurysm
Supervisors
Evaluation of the progenitor potential of monocyte/macrophage subsets in cardiovascular disease
Supervisors
Publications
Recent publications
01/02/2025Non-culprit plaque healing on serial OCT imaging and future outcome in patients with acute coronary syndromes
Atherosclerosis
CCN4 (WISP-1) reduces apoptosis and atherosclerotic plaque burden in an ApoE mouse model
Atherosclerosis
FGL2/FcγRIIB signalling mediates arterial shear stress-mediated endothelial cell apoptosis: implications for coronary artery bypass vein graft pathogenesis
International Journal of Molecular Sciences
Pharmacological Inhibition of MMP-12 Exerts Protective Effects on Angiotensin II-Induced Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice
International Journal of Molecular Sciences
WISP-1 Regulates Cardiac Fibrosis by Promoting Cardiac Fibroblasts’ Activation and Collagen Processing
Cells